Trial
NCT00572156
rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Ipsen
Collaborators
—
Condition
Insulin-like Growth Factor-1 Deficiency
Intervention
NutropinAq® (Somatropin [rDNA origin])
Why stopped
The study was prematurely terminated due to strategic reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-30